Skip to main content

Table 2 Treatment and glycemic control in the diabetic patient population (N = 186)

From: Metformin use and its effect on survival in diabetic patients with advanced non-small cell lung cancer

Characteristic Patients % (n/N)
Metformin
 Yes 59.7 (111/186)
 No 40.3 (75/186)
Glibenclamide
 Yes 32.3 (60/186)
 No 67.7 (126/186)
Insulin
 Yes 11.3 (21/186)
 No 88.7 (165/186)
Other antidiabetic medication
 Yes 5.4 (10/186)
 No 94.6 (176/186)
Basal Fasting Glucose
 Mean (± S.D.) 170 (78.5)
 Range 74–604
Glycemic Control (n = 185)a
 Proper (<130 mg/dLb) 31.2 (58/185)
 Improper (≥130 mg/dLb) 68.8 (127/185)
  1. a One patient with missing glucose values
  2. b Calculated mean serum glucose